DYSLIPIDEMIAS

Clinical trials for DYSLIPIDEMIAS explained in plain language.

Never miss a new study

Get alerted when new DYSLIPIDEMIAS trials appear

Sign up with your email to follow new studies for DYSLIPIDEMIAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 20 Not yet recruiting 1 Not yet finished but already full! 13 Completed 22 Terminated 1

Experimental drug for cholesterol and fatty liver studied in early trial

Disease control Terminated

This early-stage study tested a new medicine called LY3885125 in people with high cholesterol (dyslipidemia) and non-alcoholic fatty liver disease (NAFLD). The main goal was to check if the drug is safe and how the body processes it. The study was stopped early, so results are li…

Matched conditions: DYSLIPIDEMIAS

Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control

Last updated May 17, 2026 02:53 UTC

DYSLIPIDEMIAS

Get alerted when new DYSLIPIDEMIAS trials appear

Experimental drug for cholesterol and fatty liver studied in early trial